Los Angeles, CA – Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and Unmanned Vehicle Systems (“UVS”) sectors, is pleased to announce that Simlat has selected to incorporate Draganfly’s Vital Intelligence Technology within their Specto platform to assist first responders in handling pandemic situations.
Simlat, based in Israel and the United States, is a leading provider of next generation simulation solutions for Unmanned Aerial Systems (UAS). Simlat has developed the Specto (also called the M3SAR), a system for boosting the usage of unmanned systems by first responders for various tasks. The Specto includes algorithms intended for search and rescue operations and can host algorithms for additional applications.
Draganfly’s technology is a health and respiratory measurement platform used as a pre-screening tool to help identify possible infectious and respiratory conditions. Draganfly will process and analyze footage provided by Simlat in relation to social distancing and vital sign measurement.
“Simlat is a recognized global leader in creating outstanding systems that boosts performance and safety,” said Cameron Chell, CEO Draganfly. “We are thrilled they have chosen Draganfly to aid in accomplishing an end to end solution to help first responders better handle pandemic situations.”
“Draganfly’s Vital Intelligence technology is the missing link in our vision to create a platform for addressing situations created as a result of this and future pandemics,” said Roy Peshin CTO. “We are excited to work together to combat the spread of COVID-19 on a global and local level as well as facilitate the development of a product beneficial to pandemic control and disaster relief efforts.
About Simlat – UAS Training Solutions
Simlat is a leading provider of next generation training systems for Unmanned Aerial Systems (UAS). Simlat’s turnkey solutions enable training in various configurations accustomed to any platform, payload and mission that support commercial, civil and military applications. Simlat’s systems are available as stand-alone or integrated to autopilots, control stations and exploitation software.
Simlat supports over 120 UAS programs & training centers in 30 countries. To learn more about Simlat, please visit www.simlat.com.
About Draganfly
Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge UVS and software that revolutionize the way people do business. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer within the commercial UAV, RPAS, and UVS space, serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.
For more information on Draganfly, please visit us at www.draganfly.com.
For additional investor information, visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.otcmarkets.com/stock/DFLYF/overview or https://www.boerse-frankfurt.de/aktie/draganfly-inc.
Media Contact
Arian Hopkins
email: [email protected]
Company Contact
Email: [email protected]
Forward-Looking Statements
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements include, but are not limited to, statements with respect to the viability and continued use of the Company’s Vital Intelligence Technology and the successful utilization and integration of the technology. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at www.sedar.com. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.
